Citius Oncology Book Value Per Share Growth & History (CTOR)
Citius Oncology's book value per share was $0.54 for fiscal 2025.
View full Citius Oncology company overviewCitius Oncology annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $0.54 | -$0.11 | −16.69% |
| 2024 | 2024-09-30 | $0.64 | $0.27 | +70.46% |
| 2023 · Dec 31 | 2023-12-31 | $9.71 | $9.56 | +6688.07% |
| 2023 · Sep 30 | 2023-09-30 | $0.38 | -$0.13 | −25.69% |
| 2022 | 2022-12-31 | $0.14 | $0.15 | — |
| 2022 | 2022-09-30 | $0.51 | — | — |
| 2021 | 2021-12-31 | -$0.00 | — | — |
Citius Oncology quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | $0.38 | -$0.07 | −15.66% |
| Q2 2026 | 2026-03-31 | $0.38 | -$0.12 | −23.85% |
| Q1 2026 | 2025-12-31 | $0.69 | $0.11 | +19.37% |
| Q4 2025 | 2025-09-30 | $0.54 | -$0.11 | −16.69% |
| Q3 2025 | 2025-06-30 | $0.45 | -$6.82 | −93.78% |
| Q2 2025 | 2025-03-31 | $0.50 | -$7.98 | −94.12% |
| Q1 2025 | 2024-12-31 | $0.58 | -$9.13 | −94.06% |
| Q4 2024 | 2024-09-30 | $0.64 | $0.27 | +70.46% |
| Q2 2024 | 2024-06-30 | $7.28 | $7.28 | — |
| Q1 2024 | 2024-03-31 | $8.48 | $8.40 | +10266.40% |
| Q4 2023 · Dec 31 | 2023-12-31 | $9.71 | $9.56 | +6688.07% |
| Q4 2023 · Sep 30 | 2023-09-30 | $0.38 | $0.38 | — |
| Q2 2023 | 2023-06-30 | -$0.00 | — | — |
| Q1 2023 | 2023-03-31 | $0.08 | — | — |
| Q4 2022 | 2022-12-31 | $0.14 | $0.15 | — |
| Q3 2022 | 2022-09-30 | -$0.01 | — | — |
| Q4 2021 | 2021-12-31 | -$0.00 | — | — |
Citius Oncology book value per share trends
Between the periods ended 2021-12-31 and 2025-09-30, Citius Oncology's book value per share increased from -$0.00 to $0.54, a change of $0.54. The latest reported quarter, Q3 2026, shows $0.38.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Citius Oncology source filings ↗